Angiotensin-receptor blockers for blood pressure linked to cancer «
Links shared publicly online about this topic.
- 952total visits
Angiotensin-receptor blockers for blood pressure linked to cancer «
View full resource at lapislight.com
Tags: Cancer
Most Recently Shared on August 13, 2010 at 2:35 am By:
Angiotensin-receptor blockers for blood pressure linked to cancer http://t.co/KJkGcSh
FDA: Angiotensin receptor blockers won't raise cancer risk - latimes.com
latimes.com — “Angiotensin receptor blockers, a type of blood pressure-lowering drug, isn't associated with cancer risk, an FDA analysis concludes” View full resource at latimes.com
Most Recently Shared on June 3, 2011 at 5:25 pm By:
Blood pressure drugs not linked to cancer risk, says FDA http://fb.me/12m4RqFHx
FDA: Angiotensin receptor blockers won't raise cancer risk - latimes.com
latimes.com — “Angiotensin receptor blockers, a type of blood pressure-lowering drug, isn't associated with cancer risk, an FDA analysis concludes” View full resource at latimes.com
Most Recently Shared on June 3, 2011 at 3:21 pm By:
Blood pressure drugs not linked to cancer risk, says FDA http://lat.ms/leSpVc
No Cancer Risk From Blood Pressure Drugs, FDA Says - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “A year ago, a study in The Lancet found that angiotensin receptor blockers, a common group of blood pressure drugs, might cause cancer. Big name ARBS include Merck's Cozaar, Novartis' Diovan, Micardis from Boerhinger Ingelheim's Micardis and Benicar from Daiichi Sankyo. The FDA completed its review and found that there is no [...]” View full resource at blogs.forbes.com
Most Recently Shared on June 3, 2011 at 3:14 pm By:
No Cancer Risk From Blood Pressure Drugs, FDA Says: A year ago, a study in The Lancet found that angiot... http://onforb.es/ji3CQH #drug
FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARB” View full resource at drugs.com
Most Recently Shared on June 3, 2011 at 3:07 pm By:
FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer... http://bit.ly/m4Hb2T #drug
No Cancer Risk With Angiotensin Receptor Blockers - QualityPoint Technologies
qualitypointtech.net — “Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications following a study last year suggesting there might be a small risk. The FDA's (Food and Drug Administration's) one-year safety review reported that it found no evidence of an increased risk of cancer in over 155,000 patients in 31 randomized clinical trials...” View full resource at qualitypointtech.net
Most Recently Shared on June 3, 2011 at 5:00 am By:
No Cancer Risk With Angiotensin Receptor Blockers: Angiotensin receptor blockers (ARBs) do not increase cancer ris... http://bit.ly/mgaBVB
FDA Finds No Link Between ARBs and Cancer - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The use of angiotensin receptor blockers (ARBs) to lower blood pressure is not associated with an increased risk of developing cancer, the FDA announced after a formal safety review.” View full resource at qualitypointtech.net
Most Recently Shared on June 2, 2011 at 11:45 pm By:
FDA Finds No Link Between ARBs and Cancer: (MedPage Today) -- The use of angiotensin receptor blockers (ARBs) to l... http://bit.ly/lJjhwm
Popular Blood Pressure Meds Not Linked to Cancer FDA Says - MSN Health - High Blood Pressure
health.msn.com — “U.S. health authorities complete safety review exonerate angiotensin-receptor blockers” View full resource at health.msn.com
Most Recently Shared on June 2, 2011 at 8:51 pm By:
Popular Blood Pressure Meds Not Linked to Cancer, FDA Says: http://on-msn.com/kmWUCn
Be Heart Smart: Lower Your Blood Pressure Today! | Natural Health
totalhealthbreakthroughs.com — “Taking pills may help to lower your blood pressure But they could also wind up giving you cancer. That's according to a study published this month in the medical journal Lancet Oncology. The study authors have linked angiotensin-receptor blockers, or ARBs, and cancer. Unsuspecting millions take these drugs to lower blood pressure and manage heart conditions. Millions of people are on these drugs and it can cause a lot of excess cancer worldwide," Dr. Ilke Sipahi told the Washington Post. Dr” View full resource at totalhealthbreakthroughs.com
Most Recently Shared on August 1, 2010 at 11:47 pm By:
Be Heart Smart: Lower Your Blood Pressure Today! http://url4.eu/6fn8g
A Type of Blood Pressure Medication Increases Cancer Risk | Health Freedom News
wellnessresources.com — “Doctors continue their misguided and expanded use of blood pressure medication, thinking that if they lower BP numbers with drugs they have someone produced a better condition of health. A new study shows that with a commonly used type of blood pressure medication called angiotensin-receptor blockers increases the risk for a new cancer up to 11%.” View full resource at wellnessresources.com
Most Recently Shared on July 19, 2010 at 12:30 am By:
News and Views A Type of Blood Pressure Medication Increases Cancer Risk http://ow.ly/18bOc0
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines | NJ.com
nj.com — “The agency said it began a review of a class of drugs known as angiotensin receptor blockers after a recently published study suggested the medicines could be associated with a slight increased risk of cancer. The class of drugs includes some of the top-selling blood pressure drugs, such as Merck’s Cozaar and Avapro, a drug marketed by Bristol-Myers Squibb.” View full resource at nj.com
Most Recently Shared on July 16, 2010 at 1:51 pm By:
RT @cafepharma: FDA takes closer look at possble cancer risks of popular hypertension meds- Star Ledger, NJ Fri, 07/... http://is.gd/duiBH
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk - Health News - Health.com
news.health.com — “By Ed EdelsonHealthDay ReporterSUNDAY, June 13 (HealthDay News) — Use of a popular class of drugs for high blood pressure and heart failure is associated with a slight boost in cancer risk, a new review of data finds.The drugs are known as angiotensin-receptor blockers (ARBs) and include medicines such as telmisartan (Micardis), losartan (Cozaar, Hyzaar), [...]” View full resource at news.health.com
Most Recently Shared on June 15, 2010 at 12:07 am By:
@naturalvites Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk http://bit.ly/9lsvcm
Study Links Angiotensin-Receptor Blockers to Cancer - ABC News
abcnews.go.com — “Some widely used blood pressure drugs called angiotensin-receptor blockers may be associated with an increased risk of cancer, researchers found in a new study” View full resource at abcnews.go.com
Most Recently Shared on June 14, 2010 at 7:57 pm By:
I'll set the record straight tonight @ABCWorldNews -- Popular Blood Pressure Drug Linked to Cancer http://bit.ly/dliZec
Cardiologists discover cancer risks in blood pressure meds
labspaces.net — “University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs).” View full resource at labspaces.net
Most Recently Shared on June 14, 2010 at 1:04 pm By:
Cardiologists discover cancer risks in blood pressure meds - http://is.gd/cOOnb
Study: Common blood pressure drugs called angiotensin-receptor blockers may raise cancer risk http://bit.ly/dqM6TA - Published in Lancet Onc
reuters.com — “Study: Common blood pressure drugs called angiotensin-receptor blockers may raise cancer risk http://bit.ly/dqM6TA - Published in Lancet Onc” View full resource at reuters.com
Most Recently Shared on June 13, 2010 at 11:43 pm By:
Study: Common blood pressure drugs called angiotensin-receptor blockers may raise cancer risk http://bit.ly/dqM6TA - Published in Lancet Onc
Advertisement

